Journal of Clinical Immunology

, Volume 5, Issue 1, pp 46–54 | Cite as

Immune function in chronic active Epstein-Barr virus infection

  • Ruthann Kibler
  • David O. Lucas
  • Mary Jane Hicks
  • Bonnie T. Poulos
  • James F. Jones
Original Articles

Abstract

The spectrum of illness attributed to Epstein-Barr virus (EBV) includes patients with symptoms persisting for more than 1 year without any other obvious underlying disease. High titers of antibodies to EBV, either IgG anti-viral capsid antigen or anti-early antigen, can be demonstrated. In this study, 13 patients diagnosed as having chronic active EBV infection were examined to determine aspects of their immunologic status. Morphological examination and fluorescent antibody analysis revealed no abnormalities in the phenotypes of peripheral blood white cells present in these patients. Compared to those from healthy control individuals, mononuclear cells from the patients showed a markedly depressed ability to produce both interleukin-2 and interferon after stimulation with mitogen and a phorbol ester. Studies of natural killer (NK) cell activity revealed that unfractionated mononuclear cells from patients with chronic active EBV infection were significantly lower in killing activity compared to the control group. Fractionation procedures to enrich for large granular lymphocytes resulted in an increase in NK activity for all individuals, but killing activity still remained slightly lower in the patients than in the control group. The dysfunctions which were found in patients with chronic active EBV infection may reflect a primary defect in natural immune functions of the patients predisposing them to a chronic or intermittent clinical disease rather than a self-limiting illness. Alternatively, the abnormalities detected in these experiments may be a result of the viral infection itself.

Key words

Natural killer (NK) cell interferon interleukin-2 chronic active Epstein-Barr virus (EBV) infection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Epstein MA, Achong BG: The Epstein-Barr Virus. New York, Springer-Verlag, 1979, pp 321–350Google Scholar
  2. 2.
    Schooley RT, Hirsch MS, Colvin RB, Cosimi AV, Tolkoff-Rubin NE, McCluskey MC, Burton RC, Russell PC, Herrin JT, Delmonico FL, Giorgi JV, Henle W, Rubin RH: Association of herpesvirus infections with T-lymphocyte subset alterations, glomerulopathy and opportunistic infections after renal transplantation. N Engl J Med 308:307–313, 1983Google Scholar
  3. 3.
    Depper JM, Zvaifler NJ: The association of Epstein-Barr virus and rheumatoid arthritis. Adv Inflam Res 3:29–40, 1982Google Scholar
  4. 4.
    Pearson GR: The humoral response: Infectious mononucleosis.In Praeger Monographs in Infectious Diseases, D Schlossberg (ed). New York, Praeger, 1983, pp 1–277Google Scholar
  5. 5.
    Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO: Elevated Epstein-Barr virus anti-early antigen antibodies in patients with persistent, unexplained illness: Clinical and immunologic observations. Ann Intern Med 102:1–7, 1985Google Scholar
  6. 6.
    Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blaese RM: Persisting illness and fatigue in 23 adults: Serologic and immunologic evidence for chronic active Epstein-Barr virus infection. Ann Intern Med 102:7–16, 1985Google Scholar
  7. 7.
    Weigle KA, Sumaya CV, Montiel MM: Changes in T-lymphocyte subsets during childhood Epstein-Barr virus infectious mononucleosis. J Clin Immunol 3:151–155, 1983Google Scholar
  8. 8.
    Mangi RJ, Niederman JC, Kelleher JE, Dwyer JM, Evans AS, Kantor FS: Depression of cell-mediated immunity during acute infectious mononucleosis. N Engl J Med 291:1149–1153, 1974Google Scholar
  9. 9.
    Virelizier JL, Lenoir G, Griscelli C: Persistent Epstein-Barr virus infection in a child with hypergammaglobulinemia and immunoblastic proliferation associated with a selective effect in immune interferon secretion. Lancet 2:231–234, 1978Google Scholar
  10. 10.
    Sullivan JL, Byron KS, Brewster FE, Baker SM, Ochs HD: X-linked lymphoproliferative syndrome: Natural history of the immunodeficiency. J Clin Invest 71:1765–1778, 1983Google Scholar
  11. 11.
    Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest Suppl 97, 21:77–89, 1968Google Scholar
  12. 12.
    Julius MH, Simpson E, Herzenberg LA: A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 3:645–649, 1973Google Scholar
  13. 13.
    Timonen T, Ortaldo JR, Herberman RB: Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153:569–582, 1981Google Scholar
  14. 14.
    Timonen T, Saksela E: Isolation of human NK cells by density gradient centrifugation. J Immunol Methods 36:285–291, 1980Google Scholar
  15. 15.
    Cerottini JC, Brunner KT: In vitro assay of target cell lysis by sensitized lymphocytes.In In Vitro Methods in Cell-Mediated Immunity, BR Bloom, PR Glade (eds). New York, Academic Press, 1971, pp 369–373Google Scholar
  16. 16.
    Hoffman T, Kunkel HG: The E rosette test.In In Vitro Methods in Cell-Mediated and Tumor Immunity, BR Bloom, JR David (eds). New York, Academic Press, 1976, pp 71–81Google Scholar
  17. 17.
    Hicks MJ, Jones JF, Minnich LL, Weigle KA, Thies AC, Layton JM: Age-related changes in T- and B-lymphocyte subpopulations in the peripheral blood. Arch Path Lab Med 107:518–523, 1983Google Scholar
  18. 18.
    Gillis S: Interleukin 2: Biology and biochemistry. J Clin Immunol 3:1–13, 1983Google Scholar
  19. 19.
    Gillis S, Ferm MM, Ou W, Smith KA: T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120:2027–2032, 1978Google Scholar
  20. 20.
    Langford MP, Stanton GJ, Johnson HM: Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun 22:62–68, 1978Google Scholar
  21. 21.
    Lai PK, Alpers MP, MacKay-Scollay EM: Epstein-Barr herpesvirus infection: Inhibition by immunologically induced mediators with interferon-like properties. Int J Cancer 20:21–29, 1977Google Scholar
  22. 22.
    Thorley-Lawson DA: The transformation of adult but not newborn human lymphocytes by Epstein-Barr virus and phytohemagglutinin is inhibited by interferon: The early suppression by T cells of Epstein-Barr infection is mediated by interferon. J Immunol 126:829–833, 1981Google Scholar
  23. 23.
    Grazia-Masucci M, Bejarano MT, Masucci G, Klein E: Large granular lymphocytes inhibit thein vitro growth of autologous Epstein-Barr virus-infected B cells. Cell Immunol 76:311–321, 1983Google Scholar
  24. 24.
    Sullivan JL, Byron KS, Brewster FE, Purtilo DT: Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 210:543–545, 1980Google Scholar
  25. 25.
    Svedmyr E, Ernberg I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blomgren H, Berthold W, Henle W, Klein G: Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol 30:437–450, 1984Google Scholar
  26. 26.
    Thestrup-Pedersen K, Esmann V, Bisballe S, Jensen JR, Pallesen G, Hastrup J, Madsen M, Thorling K, Grazia-Masucci M, Saemundsen AK, Ernberg I: Epstein-Barr-virus induced lymphoproliferative disorder converting to a fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect. Lancet 2:997–1002, 1980Google Scholar
  27. 27.
    Biron CA, Welsh RM: Activation and role of natural killer cells in virus infections. Med Microbiol Immunol 170:155–172, 1982Google Scholar
  28. 28.
    Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ: Interleukin 2-mediated immune interferon (IFN-γ) production by human cells and T cell subsets. J Immunol 130:1784–1789, 1983Google Scholar
  29. 29.
    Johnson HM, Farrar WL: The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol 75:154–159, 1983Google Scholar
  30. 30.
    Papermaster V, Torres BA, Johnson HM: Evidence for suppressor T-cell regulation of human gamma interferon production. Cell Immunol 79:279–287, 1983Google Scholar
  31. 31.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M: Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med 301:1133–1137, 1979Google Scholar
  32. 32.
    Tarkkanen J, Saksela E, von Willebrand E, Lehtonen E: Suppressor cells of the human NK activity: Characterization of the cells and mechanism of action. Cell Immunol 79:265–278, 1983Google Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Ruthann Kibler
    • 1
  • David O. Lucas
    • 1
  • Mary Jane Hicks
    • 2
  • Bonnie T. Poulos
    • 1
  • James F. Jones
    • 3
  1. 1.Department of Microbiology and ImmunologyUniversity of Arizona, College of Medicine, and Southwestern Clinic and Research InstituteTucson
  2. 2.Department of PathologyUniversity of Arizona, College of MedicineTucson
  3. 3.Department of PediatricsNational Jewish Hospital and Research CenterDenver

Personalised recommendations